Quantum-Si incorporated operates the first next-generation protein sequencing platform for the healthcare industries.
| Revenue (TTM) | $2.44M |
| Gross Profit (TTM) | $1.15M |
| EBITDA | $-92.59M |
| Operating Margin | -4677.00% |
| Return on Equity | -46.50% |
| Return on Assets | -24.60% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $1.02 |
| Price-to-Book | 0.96 |
| Price-to-Sales (TTM) | 87.10 |
| EV/Revenue | 21.93 |
| EV/EBITDA | 0.63 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -62.20% |
| Shares Outstanding | $196.43M |
| Float | $177.94M |
| % Insiders | 10.59% |
| % Institutions | 32.17% |
Volatility is currently expanding